 | ||
   | ||
Email
Glossary |
|
FTC and lipoatrophy? Oct 29, 2003 Dr. Young, Is FTC one of the drugs considered a high risk for lipoatrophy? If so or not, which are, and which do you avoid perscribing? Tyler |
||||||||
 |
||||||||||
|
||||||||||
 |
| Response from Dr. Young
 Thanks for your question. Most experts believe that injury to the cell's mitochondria (a cellular organ responsible for manufacturing energy) correlate with risk of lipoatrophy. As such, the fact that d4T causes mito injury and risk of lipoatrophy are internally consistent. FTC (emtricitabine, Emtriva) is a new nucleoside medication that actually causes (in the test tube) very little, if any mitochondrial injury. Because of this, it is expected that FTC should cause little drug-associated risk of lipoatrophy. BY | ||||||||
 Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
